UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Antitumour activity of three second-line treatment combinations in patients with metastatic colorectal cancer after optimal 5-FU regimen failure: a randomised, multicentre phase II study

Annals of oncology, 2002-10, Vol.13 (10), p.1558-1567

2002

Volltextzugriff (PDF)

Phase I study of humanized monoclonal antibody AVE1642 directed against the type 1 insulin-like growth factor receptor (IGF-1R), administered in combination with anticancer therapies to patients with advanced solid tumors

Annals of oncology, 2013-03, Vol.24 (3), p.784-791

2013

Volltextzugriff (PDF)

Predictive factors of survival in patients with advanced colorectal cancer: an individual data analysis of 602 patients included in irinotecan phase III trials

Annals of oncology, 2004-07, Vol.15 (7), p.1013-1017

2004

Volltextzugriff (PDF)

Pre-operative systemic (neo-adjuvant) therapy with trastuzumab and docetaxel for HER2-overexpressing stage II or III breast cancer: results of a multicenter phase II trial

Annals of oncology, 2006-03, Vol.17 (3), p.409-414

2006

Volltextzugriff (PDF)

An open phase I study assessing the feasibility of the triple combination: oxaliplatin plus irinotecan plus leucovorin/ 5-fluorouracil every 2 weeks in patients with advanced solid tumors

Annals of oncology, 2003-03, Vol.14 (3), p.481-489

2003

Volltextzugriff (PDF)

FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR Study

Journal of clinical oncology, 2004-01, Vol.22 (2), p.229-237

2004

Volltextzugriff (PDF)

A phase I clinical and pharmacokinetic study of capecitabine (Xeloda ) and irinotecan combination therapy (XELIRI) in patients with metastatic gastrointestinal tumours

British journal of cancer, 2005-03, Vol.92 (5), p.820-826

2005

Volltextzugriff (PDF)

High prognostic significance of residual disease after neoadjuvant chemotherapy : a retrospective study in 710 patients with operable breast cancer

Breast cancer research and treatment, 2005-12, Vol.94 (3), p.255-263

2005

Volltextzugriff (PDF)

Les essais cliniques en cancérologie pédiatrique: Recommandations pour le développement des nouveaux agents anticancéreux

Therapie, 2003, Vol.58 (3), p.229-246

2003

Volltextzugriff (PDF)

Clinical trials in oncology: specific methodology problems

Therapie, 2002-07, Vol.57 (4), p.358

2002

Volltextzugriff (PDF)

Combination of Oxaliplatin Plus Irinotecan in Patients With Gastrointestinal Tumors: Results of Two Independent Phase I Studies With Pharmacokinetics

Journal of clinical oncology, 1999-06, Vol.17 (6), p.1751-1759

1999

Volltextzugriff (PDF)

Irinotecan Combined With Bolus Fluorouracil, Continuous Infusion Fluorouracil, and High-Dose Leucovorin Every Two Weeks (LV5FU2 Regimen): A Clinical Dose-Finding and Pharmacokinetic Study in Patients With Pretreated Metastatic Colorectal Cancer

Journal of clinical oncology, 1999-09, Vol.17 (9), p.2901-2908

1999

Volltextzugriff (PDF)

A Phase II study of irinotecan in patients with advanced renal cell carcinoma

Cancer, 2003-07, Vol.98 (1), p.61-65

2003

Volltextzugriff (PDF)

Risk announcement in paediatric cancerology: strengthen the therapeutic alliance

Archives de pédiatrie : organe officiel de la Société française de pédiatrie, 2008-03, Vol.15 (3), p.291-300

2008

Volltextzugriff (PDF)

Clinical trials in paediatric oncology. Recommendations for the development of new anticancer agents

Therapie, 2003-05, Vol.58 (3), p.229-246

2003

Volltextzugriff (PDF)

P3-16-08: A Phase 2, Randomized Open-Label Study of Iniparib, Administered Either Weekly or Twice-Weekly in Combination with Gemcitabine Plus Carboplatin in Patients with mTNBC

Cancer research (Chicago, Ill.), 2011-12, Vol.71 (24_Supplement), p.P3-P3-16-08

2011

Volltextzugriff (PDF)

Clinical Trials in Paediatric Oncology: Recommendations for the Development of New Anticancer Agents

Therapie, 2003-01, Vol.58 (3), p.239-246

2003

Volltextzugriff (PDF)

Larotaxel (L) in combination with trastuzumab in patients with HER2 + metastatic breast cancer (MBC): Interim analysis of an open phase II label study

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.1070-1070

2008

Volltextzugriff (PDF)

A phase I study of AVE1642, a humanized monoclonal antibody IGF-1R (insulin like growth factor1 receptor) antagonist, in patients(pts) with advanced solid tumor(ST)

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.3582-3582

2008

Volltextzugriff (PDF)

Resection of previously unresectable liver metastases from colorectal cancer (LMCRC) after chemotherapy (CT) with CPT-11/L-OHP/LV5FU (Folfirinox): A prospective phase II trial

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.3613-3613

2004

Volltextzugriff (PDF)

Resection of previously unresectable liver metastases from colorectal cancer (LMCRC) after chemotherapy (CT) with CPT-11/L-OHP/LV5FU (Folfirinox): A prospective phase II trial

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.3613-3613

2004

Volltextzugriff (PDF)

Comparison of the tolerance and efficacy of LV5FU2-CPT11 and FOLFIRI regimens in front-line treatment of advanced colorectal cancer –A pooled analysis of 254 patients included in 2 randomised trials

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.3576-3576

2004

Volltextzugriff (PDF)

Comparison of the tolerance and efficacy of LV5FU2-CPT11 and FOLFIRI regimens in front-line treatment of advanced colorectal cancer –A pooled analysis of 254 patients included in 2 randomised trials

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.3576-3576

2004

Volltextzugriff (PDF)

Relationship between high dose irinotecan (260mg/m2) and response rate, without increased toxicities in metastatic colorectal cancer (MCRC) combination with bi-weekly 5FU/FA in a phase II study

European journal of cancer (1990), 2001-04, Vol.37, p.S297-S297

2001

Volltextzugriff (PDF)

Predictive and prognostic factors in patients treated by neoadjuvant chemotherapy: A retrospective study

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.9702-9702

2004

Volltextzugriff (PDF)

1 – 25 von 28

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(27)
Tagungsberichte
(1)

Sprache

Englisch
(25)
Französisch
(5)

Erscheinungsjahr

n.n

Thema

Humans
(15)
Life Sciences & Biomedicine
(14)
Science & Technology
(14)
Biological And Medical Sciences
(12)
Medical Sciences
(12)
Middle Aged
(12)
Adult
(11)
Female
(11)
Oncology
(11)
Aged
(10)
Antineoplastic Agents
(9)
Camptothecin - Analogs & Derivatives
(9)
Chemotherapy
(9)
Male
(9)
Pharmacology. Drug Treatments
(9)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(7)
Camptothecin - Administration & Dosage
(7)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(6)
Irinotecan
(6)
Tumors
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Antitumour activity of three second-line treatment combinations in patients with metastatic colorectal cancer after optimal 5-FU regimen failure: a randomised, multicentre phase II study

Phase I study of humanized monoclonal antibody AVE1642 directed against the type 1 insulin-like growth factor receptor (IGF-1R), administered in combination with anticancer therapies to patients with advanced solid tumors

Predictive factors of survival in patients with advanced colorectal cancer: an individual data analysis of 602 patients included in irinotecan phase III trials

Pre-operative systemic (neo-adjuvant) therapy with trastuzumab and docetaxel for HER2-overexpressing stage II or III breast cancer: results of a multicenter phase II trial

An open phase I study assessing the feasibility of the triple combination: oxaliplatin plus irinotecan plus leucovorin/ 5-fluorouracil every 2 weeks in patients with advanced solid tumors

FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR Study

A phase I clinical and pharmacokinetic study of capecitabine (Xeloda ) and irinotecan combination therapy (XELIRI) in patients with metastatic gastrointestinal tumours

High prognostic significance of residual disease after neoadjuvant chemotherapy : a retrospective study in 710 patients with operable breast cancer

Les essais cliniques en cancérologie pédiatrique: Recommandations pour le développement des nouveaux agents anticancéreux

Clinical trials in oncology: specific methodology problems

Combination of Oxaliplatin Plus Irinotecan in Patients With Gastrointestinal Tumors: Results of Two Independent Phase I Studies With Pharmacokinetics

Irinotecan Combined With Bolus Fluorouracil, Continuous Infusion Fluorouracil, and High-Dose Leucovorin Every Two Weeks (LV5FU2 Regimen): A Clinical Dose-Finding and Pharmacokinetic Study in Patients With Pretreated Metastatic Colorectal Cancer

A Phase II study of irinotecan in patients with advanced renal cell carcinoma

Risk announcement in paediatric cancerology: strengthen the therapeutic alliance

Clinical trials in paediatric oncology. Recommendations for the development of new anticancer agents

P3-16-08: A Phase 2, Randomized Open-Label Study of Iniparib, Administered Either Weekly or Twice-Weekly in Combination with Gemcitabine Plus Carboplatin in Patients with mTNBC

Clinical Trials in Paediatric Oncology: Recommendations for the Development of New Anticancer Agents

Larotaxel (L) in combination with trastuzumab in patients with HER2 + metastatic breast cancer (MBC): Interim analysis of an open phase II label study

A phase I study of AVE1642, a humanized monoclonal antibody IGF-1R (insulin like growth factor1 receptor) antagonist, in patients(pts) with advanced solid tumor(ST)

Resection of previously unresectable liver metastases from colorectal cancer (LMCRC) after chemotherapy (CT) with CPT-11/L-OHP/LV5FU (Folfirinox): A prospective phase II trial

Resection of previously unresectable liver metastases from colorectal cancer (LMCRC) after chemotherapy (CT) with CPT-11/L-OHP/LV5FU (Folfirinox): A prospective phase II trial

Comparison of the tolerance and efficacy of LV5FU2-CPT11 and FOLFIRI regimens in front-line treatment of advanced colorectal cancer –A pooled analysis of 254 patients included in 2 randomised trials

Comparison of the tolerance and efficacy of LV5FU2-CPT11 and FOLFIRI regimens in front-line treatment of advanced colorectal cancer –A pooled analysis of 254 patients included in 2 randomised trials

Relationship between high dose irinotecan (260mg/m2) and response rate, without increased toxicities in metastatic colorectal cancer (MCRC) combination with bi-weekly 5FU/FA in a phase II study

Predictive and prognostic factors in patients treated by neoadjuvant chemotherapy: A retrospective study

Suchergebnisse filtern